Early B-cell factor gene association with multiple sclerosis in the Spanish population

BMC Neurology

Volumn 5, Issue , 2005, Pages

  Martínez, Alfonso ^a   Mas, Ana ^a   de las Heras, Virginia ^a   Arroyo, Rafael ^a   Fernández Arquero, Miguel ^a   de la Concha, Emilio G ^a   Urcelay, Elena ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; EARLY B CELL FACTOR 1; HLA DR ANTIGEN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; EBF1 PROTEIN, HUMAN; PRIMER DNA; TRANSACTIVATOR PROTEIN;

ARTICLE; B LYMPHOCYTE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PATHOGENESIS; RISK FACTOR; SPAIN; CAUCASIAN; CHROMOSOME 5; CHROMOSOME MAP; COMPARATIVE STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC MARKER; GENETICS; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; REFERENCE VALUE;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 5; DNA PRIMERS; DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC MARKERS; HUMANS; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK FACTORS; SPAIN; TRANS-ACTIVATORS;

EID: 27744547942     PISSN: 14712377     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-5-19     Document Type: Article

References (44)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis. N Engl J Med 2000, 343(13):938-952.
2. Jersild C, Svejgaard A, Fog T: HL-A antigens and multiple sclerosis. Lancet 1972, 1(7762):1240-1241.
3. Olerup O, Hillert J: HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991, 38(1):1-15.
4. Owens GP, Kraus H, Burgoon MP, Smith-Jensen T, Devlin ME, Gilden DH: Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol 1998, 43(2):236-243.
5. Qin Y, Duquette P, Zhang Y, Talbot P, Poole R, Antel J: Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest 1998, 102(5):1045-1050.
6. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338(5):278-285.
7. De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, Matthews PM, Arnold DL: Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001, 58(1):65-70.
8. De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, Antel JP, Arnold DL Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998, 121 (Pt 8)):1469-1477.
9. Pitt D, Werner P, Raine CS: Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000, 6(1):67-70.
10. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA: Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 2003, 33(3):366-374.
11. Busslinger M: Transcriptional control of early B cell development. Annu Rev Immunol 2004, 22:55-79.
12. Lin H, Grosschedl R: Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 1995, 376(6537):263-267.
13. Lin KI, Tunyaplin C, Calame K: Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol Rev 2003, 194:19-28.
14. Corcione A, Casazza S, Ferretti E, Giunti D, Zappia E, Pistorio A, Gambini C, Mancardi GL, Uccelli A, Pistoia V: Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A 2004, 101(30):11064-11069.
15. Wang MM, Reed RR: Molecular cloning of the olfactory neuronal transcription factor Olf-1 by genetic selection in yeast. Nature 1993, 364(6433):121-126.
16. Prasad BC, Ye B, Zackhary R, Schrader K, Seydoux G, Reed RR: unc-3, a gene required for axonal guidance in Caenorhabditis elegans, encodes a member of the O/E family of transcription factors. Development 1998, 125(8):1561-1568.
17. Kudrycki KE, Buiakova O, Tarozzo G, Grillo M, Walters E, Margolis FL: Effects of mutation of the Olf-1 motif on transgene expression in olfactory receptor neurons. J Neurosci Res 1998, 52(2):159-172.
18. Devireddy LR, Jones CJ: Olf-1, a neuron-specific transcription factor, can activate the herpes simplex virus type 1-infected cell protein 0 promoter. J Biol Chem 2000, 275(1):77-81.
19. Baig S, Olsson O, Olsson T, Love A, Jeansson S, Link H: Cells producing antibody to measles and herpes simplex virus in cerebrospinal fluid and blood of patients with multiple sclerosis and controls. Clin Exp Immunol 1989, 78(3):390-395.
20. Ferrante P, Mancuso R, Pagani E, Guerini FR, Calvo MG, Saresella M, Speciale L, Caputo D: Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack. J Neurovirol 2000, 6 Suppl 2:S109-114.
21. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13(3):227-231.
22. Martinez Doncel A, Rubio A, Arroyo R, de las Heras V, Martin C, Fernandez-Arquero M, de la Concha EG: Interleukin-10 polymorphisms in Spanish multiple sclerosis patients. J Neuroimmunol 2002, 131(1-2):168-172.
23. Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A, Daly MJ, De Jager PL, Walsh E, Lander ES et al: A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005, 77(3):454-467.
24. Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR et al: A second-generation genomic screen for multiple sclerosis. Am J Hum Genet 2004, 75(6):1070-1078.
25. Serrano-Fernandez P, Ibrahim SM, Zettl UK, Thiesen HJ, Godde R, Epplen JT, Moller S: Intergenomic consensus in multifactorial inheritance loci: the case of multiple sclerosis. Genes Immun 2004, 5(8):615-620.
26. Mansson R, Tsapogas P, Akerlund M, Lagergren A, Gisler R, Sigvardsson M: Pearson correlation analysis of microarray data allows for the identification of genetic targets for early B-cell factor. J Biol Chem 2004, 279(17):17905-17913.
27. Maimone D, Guazzi GC, Annunziata P: IL-6 detection in multiple sclerosis brain. J Neurol Sci 1997, 146(1):59-65.
28. Navikas V, Matusevicius D, Soderstrom M, Fredrikson S, Kivisakk P, Ljungdahl A, Hojeberg B, Link H: Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 1996, 64(1):63-69.
29. Okuda Y, Sakoda S, Saeki Y, Kishimoto T, Yanagihara T: Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein. J Neuroimmunol 2000, 105(2):120-123.
30. Lee VM, Goedert M, Trojanowski JQ: Neurodegenerative tauopathies. Annu Rev Neurosci 2001, 24:1121-1159.
31. Ebneth A, Godemann R, Starner K, Illenberger S, Trinczek B, Mandelkow E: Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol 1998, 143(3):777-794.
32. Kapaki E, Paraskevas GP, Michalopoulou M, Kilidireas K: Increased cerebrospinal fluid tau protein in multiple sclerosis. Eur Neurol 2000, 43(4):228-232.
33. Schneider A, Araujo GW, Trajkovic K, Herrmann MM, Merkler D, Mandelkow EM, Weissert R, Simons M: Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis. J Biol Chem 2004, 279(53):55833-55839.
34. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS et al: Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307(5713):1282-1288.
35. Surinya KH, Cox TC, May BK: Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem 1998, 273(27):16798-16809.
36. Ghayor C, Herrouin JF, Chadjichristos C, Ala-Kokko L, Takigawa M, Pujol JP, Galera P: Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration. J Biol Chem 2000, 275(35):27421-27438.
37. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Hori M, Nakamura Y, Tanaka T: Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002, 32(4):650-654.
38. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M et al: An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003, 35(4):341-348.
39. Villar LM, Masjuan J, Gonzalez-Porque P, Plaza J, Sadaba MC, Roldan E, Bootello A, Alvarez-Cermeno JC: Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis. Ann Neurol 2003, 53(2):222-226.
40. Villar LM, Sadaba MC, Roldan E, Masjuan J, Gonzalez-Porque P, Villarrubia N, Espino M, Garcia-Trujillo JA, Bootello A, Alvarez-Cermeno JC: Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. J Clin Invest 2005, 115(1):187-194.
41. Sellebjerg F, Christiansen M, Garred P: MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis. Mult Scler 1998, 4(3):127-131.
42. Mead RJ, Singhrao SK, Neal JW, Lassmann H, Morgan BP: The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol 2002, 168(1):458-465.
43. Uccelli A, Aloisi F, Pistoia V: Unveiling the enigma of the CNS as a B-cell fostering environment. Trends Immunol 2005, 26(5):254-259.
44. Akerblad P, Lind U, Liberg D, Bamberg K, Sigvardsson M: Early B-cell factor (O/E-1) is a promoter of adipogenesis and involved in control of genes important for terminal adipocyte differentiation. Mol Cell Biol 2002, 22(22):8015-8025.